← FDA Drug Approvals (Drugs@FDA)

OSELTAMIVIR PHOSPHATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD III · Approved 2018-02-23

Drug application

FDA Application #

ANDA209438

Application type

Abbreviated New Drug Application (Generic)

Brand name

OSELTAMIVIR PHOSPHATE

Generic name

OSELTAMIVIR PHOSPHATE

Active ingredients

OSELTAMIVIR PHOSPHATE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

HETERO LABS LTD III

Manufacturer

Camber Pharmaceuticals, Inc.

First approval

2018-02-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown